Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Fedja Farowski
Combined phage therapy and faecal microbiota transplantation to treat recurrent urinary tract infection: a case series
Abstract Recurrent urinary tract infections are recalcitrant and difficult-to-treat bacterial infections that primarily affect women. Here we combine phage therapy with faecal microbiota transplantation to decolonize the urinary and intestinal reservoirs of patients with recurrent urinary tract infections. Three women received oral and intravesical phage therapy for 8 days, and two underwent subsequent faecal microbiota transplantation.
Validation of an Automated Fluorescence- and Image-Based Viable Cell Counting Method for Fecal Microbiota Transplantation Drug Products
1 Introduction Fecal microbiota transplantation (FMT) has become a standard of care in the treatment of recurrent Clostridioides difficile infections (CDI), where conventional antibiotic therapy often fails. In recent years, FMT has also gained attention as a potential treatment for a range of gastrointestinal and even extraintestinal diseases, including inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), and metabolic diseases [1].
Torque teno virus‐DNA load as individual cytomegalovirus risk assessment parameter upon allogeneic hematopoietic stem cell transplantation
What is the new aspect of your work? We investigated the correlation of Torque teno virus (TTV) levels with risk of reactivation of different viruses esp. Cytomegalovirus (CMV) in the early phase after allogeneic hematopoietic stem cell transplantation (allo-HSCT). What is the central finding of your work? CMV serostatus of the recipient and a TTV load below 1000 copies/mL upon allo-HSCT were significantly associated with an increased incidence of CMV infection or reactivation.
Fecal microbiota transfer for refractory intestinal graft‐versus‐host disease - experience from two German tertiary centers
ORIGINAL ARTICLE Felix Goeser Corresponding Author Felix.Goeser@ukbonn.de orcid.org/0000-0003-3190-9981 Department of Internal Medicine I, University Hospital Bonn, Bonn, Germany German Center for Infection Research (DZIF), partner site Bonn‐Cologne, Germany German Clinical Microbiome Study Group (GCMSG) Corresponding author Felix Goeser, MD, Address: Venusberg Campus 1, D‐53127 Bonn, Germany Email: Felix.Goeser@ukbonn.de Search for more papers by this author Fedja Farowski German Center for...
Usability of rectal swabs for microbiome sampling in a cohort study of hematological and oncological patients
Loading metrics Open Access Peer-reviewed Research Article Lena M. Biehl , Debora Garzetti , Fedja Farowski, Diana Ring, Martin B. Koeppel, Holger Rohde, Philippe Schafhausen, Bärbel Stecher, Maria J. G. T. Vehreschild Lena M. Biehl, Debora Garzetti, Fedja Farowski, Diana Ring, Martin B. Koeppel, Holger Rohde, Philippe Schafhausen, Bärbel Stecher, Maria J. G. T.
Low penetration of caspofungin into cerebrospinal fluid following intravenous administration of standard doses
Publication HistoryPublished online: May 17, 2017Accepted: February 22, 2017; Received: November 24, 2016;
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Fedja
Contact Fedja, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack